Modulation of the EMT/MET Process by E-Cadherin in Airway Epithelia Stress Injury.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
30 04 2021
Historique:
received: 25 03 2021
revised: 26 04 2021
accepted: 28 04 2021
entrez: 5 5 2021
pubmed: 6 5 2021
medline: 21 9 2021
Statut: epublish

Résumé

Persistent injury and the following improper repair in bronchial epithelial cells are involved in the pathogenesis of airway inflammation and airway remodeling of asthma. E-cadherin (ECAD) has been shown to be involved in airway epithelium injury repair, but its underlying mechanisms to this process is poorly understood. Here, we describe a previously undetected function of ECAD in regulating the balance of EMT and MET during injury repair. Injury in mice and human bronchial epithelial cells (HBECs) was induced by successive ozone stress for 4 days at 30 min per day. ECAD overexpression in HBECs was induced by stable transfection. EMT features, transforming growth factor beta1 (TGF-β1) secretion, transcriptional repressor Snail expression, and β-catenin expression were assayed. Ozone exposure and then removal successfully induced airway epithelium injury repair during which EMT and MET occurred. The levels of TGF-β1 secretion and Snail expression increased in EMT process and decreased in MET process. While ECAD overexpression repressed EMT features; enhanced MET features; and decreased TGF-β1 secretion, Snail mRNA level, and β-catenin protein expression. Moreover, activating β-catenin blocked the effects of ECAD on EMT, MET and TGF-β1 signaling. Our results demonstrate that ECAD regulates the balance between EMT and MET, by preventing β-catenin to inhibit TGFβ1 and its target genes, and finally facilitates airway epithelia repair.

Identifiants

pubmed: 33946207
pii: biom11050669
doi: 10.3390/biom11050669
pmc: PMC8144967
pii:
doi:

Substances chimiques

Cadherins 0
Snail Family Transcription Factors 0
Transforming Growth Factor beta 0
beta Catenin 0
Ozone 66H7ZZK23N

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Nature Science Foundation of China
ID : 81670002, 31671188, and 81970033
Organisme : Hunan Natural Science Foundation
ID : 2019JJ40329 and 2020JJ4776

Références

Oncogene. 2004 Jul 15;23(32):5532-42
pubmed: 15107817
Cytokine. 2013 Apr;62(1):1-21
pubmed: 23490414
J Biomed Biotechnol. 2011;2011:567305
pubmed: 22007144
PLoS One. 2015 Mar 13;10(3):e0119717
pubmed: 25768308
J Cell Sci. 2013 Jan 15;126(Pt 2):393-401
pubmed: 23525005
J Clin Invest. 2009 Jun;119(6):1429-37
pubmed: 19487819
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
J Cell Sci. 2008 Mar 15;121(Pt 6):727-35
pubmed: 18322269
PLoS One. 2016 Oct 4;11(10):e0163967
pubmed: 27701444
Biochem Pharmacol. 2013 Nov 15;86(10):1419-29
pubmed: 24035834
Cell. 2009 Nov 25;139(5):871-90
pubmed: 19945376
Am J Physiol. 1995 Mar;268(3 Pt 1):L347-60
pubmed: 7900815
Acta Anat (Basel). 1995;154(1):8-20
pubmed: 8714286
Nat Rev Nephrol. 2016 Jun;12(6):325-38
pubmed: 27108839
Inflamm Res. 2013 Jul;62(7):669-80
pubmed: 23625042
Sci Rep. 2018 Sep 11;8(1):13644
pubmed: 30206265
Curr Opin Pulm Med. 2018 Jan;24(1):56-62
pubmed: 29076828
Oncol Rep. 2017 Feb;37(2):713-720
pubmed: 28035402
Hepatology. 2010 Dec;52(6):2053-64
pubmed: 20890948
Respir Res. 2014 Nov 27;15:151
pubmed: 25427655
Adv Exp Med Biol. 2018;1095:101-110
pubmed: 30229551
Nat Rev Mol Cell Biol. 2005 Aug;6(8):622-34
pubmed: 16025097
Exp Physiol. 2018 Aug;103(8):1157-1169
pubmed: 29791759
Exp Ther Med. 2017 Aug;14(2):1783-1788
pubmed: 28810650
Toxicol Pathol. 2019 Dec;47(8):993-1003
pubmed: 31537180
Nat Rev Mol Cell Biol. 2003 Aug;4(8):657-65
pubmed: 12923528
Biochem Biophys Res Commun. 2010 Jun 25;397(2):290-5
pubmed: 20510671
J Cell Sci. 2012 Oct 1;125(Pt 19):4417-22
pubmed: 23165231
Am J Physiol Lung Cell Mol Physiol. 2014 Sep 15;307(6):L471-81
pubmed: 25063800
Trends Cell Biol. 2004 Aug;14(8):427-34
pubmed: 15308209
J Cell Sci. 2010 Oct 15;123(Pt 20):3467-77
pubmed: 20930141
Sci Rep. 2018 Sep 5;8(1):13275
pubmed: 30185803
Cell Tissue Res. 2016 Sep;365(3):495-506
pubmed: 27461257
J Invest Dermatol. 2003 Aug;121(2):219-30
pubmed: 12880412
Virchows Arch. 2008 Dec;453(6):617-25
pubmed: 18949487
Nat Rev Cancer. 2009 Apr;9(4):265-73
pubmed: 19262571
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099

Auteurs

Li Han (L)

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410007, China.
Department of Physiology, School of Basic Medicine, Changsha Medical University, Changsha 410219, China.

Huaiqing Luo (H)

Department of Physiology, School of Basic Medicine, Changsha Medical University, Changsha 410219, China.

Wenjie Huang (W)

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410007, China.

Jiang Zhang (J)

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410007, China.

Di Wu (D)

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410007, China.

Jinmei Wang (J)

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410007, China.

Jiao Pi (J)

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410007, China.

Chi Liu (C)

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410007, China.

Xiangping Qu (X)

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410007, China.

Huijun Liu (H)

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410007, China.

Xiaoqun Qin (X)

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410007, China.

Yang Xiang (Y)

Department of Physiology, School of Basic Medical Science, Central South University, Changsha 410007, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH